• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts by “Healthday News”
View Post

Bimekizumab Tops Secukinumab for Plaque Psoriasis

In HealthDay News
by Healthday
April 26, 2021

In second study, bimekizumab showed noninferiority and superiority to adalimumab for moderate-to-severe disease

View Post

COVID-19 Vaccinations Now Mandatory for Houston Methodist Hospital Workers

In HealthDay News, OBGYN & Women's Health
by Healthday
April 26, 2021

In March, health system gave vaccinated workers an extra $500 and warned that at some point the shots would no longer be voluntary

View Post

Tocilizumab Preserves Lung Function in Early Systemic Sclerosis

In HealthDay News
by Healthday
April 23, 2021

Stabilization of lung function independent of the extent of quantitative radiographic interstitial lung disease or fibrosis at baseline

View Post

Psoriasis Incidence in the United States Remains Steady

In HealthDay News
by Healthday
April 23, 2021

New diagnosis of psoriasis increases with age, is similar between sexes, and is greatest among Whites

View Post

ACP Offers Guidance on Antibiotic Duration for Common Infections

In HealthDay News, OBGYN & Women's Health
by Healthday
April 21, 2021

Best practices recommend limiting antibiotics to five days for COPD exacerbations, acute uncomplicated bronchitis

View Post

Proportion of Black Physicians Has Changed Little Since 1900

In HealthDay News, OBGYN & Women's Health
by Healthday
April 20, 2021

Racial income differences were statistically significant each survey year, with difference of $50,000 in 2018

View Post

Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy

In HealthDay News
by Healthday
April 20, 2021

Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days

View Post

Nearly Half of Older Adults Use Online Physician Ratings

In HealthDay News, OBGYN & Women's Health
by Healthday
April 16, 2021

Online ratings perceived to be very important nearly as often as word-of-mouth recommendations from family and friends

View Post

Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common

In HealthDay News
by Healthday
April 16, 2021

About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects

View Post

Children With Worse Atopic Dermatitis More Likely to Have Learning Disabilities

In HealthDay News
by Healthday
April 15, 2021

Findings independent of socioeconomic characteristics, onset age, and other related disorders

  • Page 22 of 151
  • ←
  • 1
  • ...
  • 21
  • 22
  • 23
  • ...
  • 151
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer